S. 5732U.S. Congress
A bill to amend the 21st Century Cures Act and the Public Health Service Act to ensure that expenses relating to the acquisition or use of devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances, including test strips, are allowable expenses under certain grant programs.
Introduced
Nov 17, 2026: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.